The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Prolactinoma
Abstract
A 22-year-old woman who wants to become pregnant has had no menses since she discontinued the use of an oral contraceptive one year ago, and recently, galactorrhea developed. She takes no medications and has had no headaches, visual loss, dyspareunia, or decreased libido. A test for serum human chorionic gonadotropin is negative, the thyrotropin level is normal, and the serum prolactin level is 95 μg per liter. Magnetic resonance imaging reveals a mass, 3 mm in diameter, in the anterior lobe of the pituitary. How should she be treated?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea
Webster, J., Piscitelli, G., Polli, A., Ferrari, C. I., Ismail, I., & Scanlon, M. F. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410063311403 · Cited by 699
Prolactin-Secreting Tumors and Hypogonadism in 22 Men
Carter, J. N., Tyson, J. E., Tous, G., Van Vliet, S., Faiman, C., & Friesen, H. G. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810192991602 · Cited by 479
Dopamine Agonists and Pituitary Tumor Shrinkage
BEVAN, J. S., WEBSTER, J., Burke, C. W., & Scanlon, M. F. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-220 · Cited by 469
MOLITCH, M. E., ELTON, R. L., BLACKWELL, R. E., CALDWELL, B., CHANG, R. J., JAFFE, R., JOPLIN, G., ROBBINS, R. J., TYSON, J., & THORNER, M. O. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-4-698 · Cited by 435
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
Colao, A., Di Sarno, A., Cappabianca, P., Di Somma, C., Pivonello, R., & Lombardi, G. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022657 · Cited by 336
Surgery during pregnancy and fetal outcome
Brodsky, J. B., Cohen, E. N., Brown, B. W., Wu, M. L., & Whitcher, C. E. (1980) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)32785-5 · Cited by 315
Serri, O., Rasio, E., Beauregard, H., Hardy, J., & Somma, M. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090505 · Cited by 301
Prolactinomas Resistant to Standard Dopamine Agonists Respond to Chronic Cabergoline Treatment
Colao, A. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.3.876 · Cited by 276
The Natural History of Untreated Hyperprolactinemia: A Prospective Analysis*
SCHLECHTE, J., DOLAN, K., SHERMAN, B., CHAPLER, F., & LUCIANO, A. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-2-412 · Cited by 271
Self-citationPregnancy and the Hyperprolactinemic Woman
Molitch, M. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505233122106 · Cited by 254
David, S. R., Taylor, C. C., Kinon, B. J., & Breier, A. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80086-7 · Cited by 237
Augmentation of prolactin secretion by estrogen in hypogonadal women
Yen, S. S., Ehara, Y., & Siler, T. M. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107600 · Cited by 222
SIEVERTSEN, G. D., LIM, V. S., NAKAWATASE, C., & FROHMAN, L. A. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-5-846 · Cited by 207
Effects of Prolactin and Estrogen Deficiency in Amenorrheic Bone Loss*
KLIBANSKI, A., BILLER, B. M. K., ROSENTHAL, D. I., SCHOENFELD, D. A., & SAXE, V. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-1-124 · Cited by 182
Surgical Treatment of Prolactin-Secreting Pituitary Adenomas: Early Results and Long-Term Outcome
Losa, M. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3180 · Cited by 181
Pregnancy outcome after treatment with the ergot derivative, cabergoline
Robert, E., Musatti, L., Piscitelli, G., & Ferrari, C. I. (1996) · Reproductive Toxicology · doi:10.1016/0890-6238(96)00063-9 · Cited by 178
Pregnancy outcome after cabergoline treatment in early weeks of gestation
Ricci, E. D., Parazzini, F., Motta, T., Ferrari, C. I., Colao, A., Clavenna, A., Rocchi, F., Gangi, E., Paracchi, S., Gasperi, M., et al. (2002) · Reproductive Toxicology · doi:10.1016/s0890-6238(02)00055-2 · Cited by 157
Prolactin inhibits oestrogen synthesis in the ovary
Dorrington, J. H., & Gore‐Langton, R. E. (1981) · Nature · doi:10.1038/290600a0 · Cited by 153
Thyroid Hormone Inhibition of the Prolactin Response to Thyrotropin-Releasing Hormone
Snyder, P. J., JACOBS, L. S., Utiger, R. D., & Daughaday, W. H. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107421 · Cited by 153
Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas
March, C. M., Kletzky, O. A., Davajan, V., Teal, J. S., Weiss, M., Apuzzo, M. L. J., Marrs, R. P., & Mishell, D. R. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90553-6 · Cited by 149
Low Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas
Liuzzi, A., DALLABONZANA, D., OPPIZZI, G., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509123131103 · Cited by 139
High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas
St‐Jean, E., Blain, F., & Comtois, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.663486.x · Cited by 133
Long‐term follow‐up of patients with hyperprolactinaemia
Jeffcoate, W. J., Pound, N., Sturrock, N. D. C., & Lambourne, J. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00824.x · Cited by 129
y Revuelta, J. L. G. D. R., Lal, S., Ettigi, P. G., Hontela, S., Müller, H., & Friesen, H. G. (1976) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1976.tb01953.x · Cited by 126
CURRENT APPROACHES TO IMAGING OF THE SELLAR REGION AND PITUITARY
Naidich, M. J., & Russell, E. J. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70057-8 · Cited by 119
Bone Marker and Bone Density Responses to Dopamine Agonist Therapy in Hyperprolactinemic Males
Di Somma, C. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.807 · Cited by 117
The natural history of untreated microprolactinomas
Sisam, D. A., Sheehan, J. P., & Sheeler, L. R. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59292-9 · Cited by 116
Prolactin-Secreting Pituitary Tumors in Amenorrheic Women: A Comprehensive Study*
Schlechte, J., Sherman, B. M., Halmi, N. S., VanGilder, J. C., Chapler, F. K., Dolan, K. D., Granner, D. K., DUELLO, T. M., & Harris, C. E. (1980) · Endocrine Reviews · doi:10.1210/edrv-1-3-295 · Cited by 116
Self-citationKonopka, P., Raymond, J. P., Merceron, R. E., & Sénèze, J. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90968-7 · Cited by 110
Verlaat, J. W. V., & CROUGHS, R. J. M. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb00289.x · Cited by 108
Cabergoline in the Treatment of Hyperprolactinemia: A Study in 455 Patients
Verhelst, J. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.7.2518 · Cited by 107
MOULT, P. J. A., REES, L. H., & BESSER, G. M. (1982) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1982.tb03159.x · Cited by 104
EFFECT OF DOPAMINE AGONIST WITHDRAWAL AFTER LONG-TERM THERAPY IN PROLACTINOMAS
Johnston, D. G., Taylor, P. K., Watson, M., et al. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90480-x · Cited by 103
Forearm and Vertebral Bone Mineral in Treated and Untreated Hyperprolactinemic Amenorrhea*
Schlechte, J., El-Khoury, G. Y., Kathol, M. H., & Walkner, L. M. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-1021 · Cited by 103
Self-citationNecrotic Changes in Prolactinomas after Long Term Administration of Bromocriptine*
Gen, M., Uozumi, T., Ohta, M., et al. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-463 · Cited by 98
Corenblum, B., & Donovan, L. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55819-1 · Cited by 97
Clinical history and outcome of 59 patients with idiopathic hyperprolactinemia
Sluijmer, A. V., & Lappöhn, R. E. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55139-5 · Cited by 92
LONG‐TERM TREATMENT OF HYPERPROLACTINAEMIA WITH BROMOCRIPTINE: EFFECT OF DRUG WITHDRAWAL
Wang, C.-L., Lam, K. S. L., C., J. T., et al. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb01163.x · Cited by 78
Effects of methyldopa on prolactin and growth hormone.
Steiner, J. A., CASSAR, J., MASHITER, K., Dawes, I., Fraser, T. R., & Breckenridge, A. (1976) · BMJ · doi:10.1136/bmj.1.6019.1186 · Cited by 62
Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas
Arafah, B. M., Nekl, K. E., Gold, R. S., & Selman, W. R. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530591 · Cited by 60
Pituitary adenomas and oral contraceptives: a multicenter case-control study
Pituitary Adenoma Study Group (1983) · Fertility and Sterility · doi:10.1016/s0015-0282(16)47113-x · Cited by 58
Urban, R. J., & Veldhuis, J. D. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90645-8 · Cited by 56
Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function
WARFIELD, A., FINKEL, D. M., SCHATZ, N. J., SAVINO, P. J., & SNYDER, P. J. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-6-783 · Cited by 47
The Effect of Combined Estrogen/Progestogen Treatment in Women with Hyperprolactinemic Amenorrhea
Fahy, U., Foster, P. A., Torode, H. W., Hartog, M., & Hull, M. G. R. (1992) · Gynecological Endocrinology · doi:10.3109/09513599209015553 · Cited by 41
Hyperprolactinemia-galactorrhea induced by verapamil
Fearrington, E. L., Rand, C. H., & Rose, J. D. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90336-3 · Cited by 41
Long-Term Follow-Up of Prolactinomas: Normoprolactinemia after Bromocriptine Withdrawal
Passos, V. Q. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3578 · Cited by 39
Breast Examination does not Elevate Serum Prolactin
Jarrell, J. F., Franks, S., McInnes, R. A., Gemayel, K., Guyda, H. J., Arronet, G. H., & Naftolin, F. N. (1980) · Fertility and Sterility · doi:10.1016/s0015-0282(16)44476-6 · Cited by 31
Prolactin secretion and menstrual function after long-term bromocriptine treatment
Rasmussen, C., Bergh, T., & WIDE, L. E. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59462-x · Cited by 26
Cited by
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline
Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1692 · Cited by 1,844
Self-citationGuidelines of the Pituitary Society for the diagnosis and management of prolactinomas
Casanueva, F. F., Molitch, M. E., Schlechte, J. A., Abs, R., Bonert, V., Bronstein, M. D., Brue, T., Cappabianca, P., Colao, A., Fahlbusch, R., et al. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02562.x · Cited by 829
Self-citationPeuskens, J., Pani, L., Detraux, J., & De Hert, M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0157-3 · Cited by 350
Place of Cabergoline in Acromegaly: A Meta-Analysis
Sandret, L., Maison, P., & Chanson, P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2443 · Cited by 314
Hyperprolactinemia and Prolactinomas
Mancini, T., Casanueva, F. F., & Giustina, A. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.10.013 · Cited by 256
Metadata
- Authors
- Schlechte, J. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-11-20
- Volume
- 349
- Issue
- 21
- Pages
- 2035-2041
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2191930503
- Cited by
- 258
- References
- 48
- FWCI
- 7.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.